Nina Cramer
Overview
Explore the profile of Nina Cramer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simonis A, Kreer C, Albus A, Rox K, Yuan B, Holzmann D, et al.
Cell
. 2023 Nov;
186(23):5098-5113.e19.
PMID: 37918395
Drug-resistant Pseudomonas aeruginosa (PA) poses an emerging threat to human health with urgent need for alternative therapeutic approaches. Here, we deciphered the B cell and antibody response to the virulence-associated...
2.
Rosenboom I, Oguz S, Ludemann I, Ringshausen F, Rademacher J, Sedlacek L, et al.
ERJ Open Res
. 2023 Jun;
9(3).
PMID: 37377651
https://bit.ly/3lIfD2X.
3.
Cramer N, Klockgether J, Tummler B
Curr Opin Immunol
. 2023 Apr;
83:102328.
PMID: 37116385
The chronic infections of cystic fibrosis (CF) airways with Pseudomonas aeruginosa are a paradigm of how environmental bacteria can conquer, adapt, and persist in an atypical habitat and successfully evade...
4.
Kuschnerow P, Munder A, de Buhr N, Morgelin M, Jirmo A, Ackermann M, et al.
iScience
. 2023 Apr;
26(4):106475.
PMID: 37096049
Chronic airway infections with are the major co-morbidity in most people with cystic fibrosis (CF) sustained by neutrophils as the major drivers of lung inflammation, damage, and remodeling. Phagocytosis assays...
5.
Hamed M, Abdelsamie A, Rox K, Schutz C, Kany A, Rohrig T, et al.
Adv Sci (Weinh)
. 2023 Jan;
10(5):e2204443.
PMID: 36596691
Pseudomonas aeruginosa (PA) is an opportunistic human pathogen, which is involved in a wide range of dangerous infections. It develops alarming resistances toward antibiotic treatment. Therefore, alternative strategies, which suppress...
6.
Cramer N, Nawrot M, Wege L, Dorda M, Sommer C, Danov O, et al.
Front Cell Infect Microbiol
. 2022 Sep;
12:992214.
PMID: 36081773
Chronic respiratory infections with the gram-negative bacterium are an important co-morbidity for the quality of life and prognosis of people with cystic fibrosis (CF). Such long-term colonization, sometimes lasting up...
7.
Cramer N, Fischer S, Hedtfeld S, Dorda M, Tummler B
Environ Microbiol
. 2020 Jan;
22(7):2536-2549.
PMID: 31985137
The metabolically versatile Pseudomonas aeruginosa inhabits biotic and abiotic environments including the niche of cystic fibrosis (CF) airways. This study investigated how the adaptation to CF lungs affects the within-clone...
8.
Cramer N, Sedlacek L, Tummler B, Welte T
Eur Respir J
. 2019 Jan;
53(3).
PMID: 30635293
No abstract available.
9.
Klockgether J, Cramer N, Fischer S, Wiehlmann L, Tummler B
Am J Respir Cell Mol Biol
. 2018 Feb;
59(2):246-256.
PMID: 29470920
Chronic airway infections with Pseudomonas aeruginosa determine morbidity in most individuals with cystic fibrosis (CF). P. aeruginosa may persist for decades in CF lungs, which provides a rare opportunity to...
10.
Hilbert T, Steinhagen F, Senzig S, Cramer N, Bekeredjian-Ding I, Parcina M, et al.
J Surg Res
. 2017 May;
211:126-136.
PMID: 28501108
Background: Experimental animal models are indispensable components of preclinical sepsis research. Reproducible results highly rely on defined and invariant baseline conditions. Our hypothesis was that the murine gut microbiota varies...